Abstract:, anidulafungin ( AFG ,and combinationsof FLC + AFG,AFG + AMB,andFLC + AMBagainst 17 C.albicans isolates obtained from the oral cavity of cancer patients. Isolates that had not been exposed to antifungals, served as a control group. Colony counts were performed at 0, 2, 4, 6, and 24 h after a brief ( 1 h ) antifungal exposure. Results: The FLC had no detectable post-antifungal effect independent of antifungal concentration and resembled drug-free FLC ( control ) . When all AMB and AFG were compared with FLC, significant variations in the post-antifungal effect were observed. Combining AFG and AMB with FLC resulted in effective activity compared to FLC alone. Combination regimens were rated as indifferent in general. Interestingly, low dosages of the AFG displayed increasing fungistatic action as it neared a fungistatic endpoint against C. albicans isolates ( n = 17 ) . Conclusion: Our findings suggest that brief exposure to AFG, in combination with FLC and AMB, at low concentrations of the medicines utilized, could be effective in the evaluation and optimization of new dosage regimens to manage candidiasis. However, future research will look at the clinical utility of our findings. albicans is the most common cause of nosocomial and are with morbidity and in However, limited therapeutic approaches against invasive candidiasis are available. The rise in antifungal resistance highlights the urgent need to develop new therapeutic options and novel this was an in regard of the showed a significant decrease in the number of loads,similar to the group with ATTAF-1 and ATTAF-2. Nevertheless, the results this study that the use of and ATTAF-2 as a therapeutic agent can exert significant in and in vivo antifungal effects C.albicans ,increasing animal and significantly decreasing loads. Conclusion: Although we have identified two new compounds, ATTAF-1 and ATTAF-2, as novel promising Candidates for the of studies of ATTAF-1 and ATTAF-2 activity and their action mechanisms in animal models are warranted to enhance our understanding and establish their efficacy. Antifungal-resistant dermatophytosis is an emerging threat with cases of chronic,recurrent infection reported from several countriesincluding India. Additionally, the rapidspread of infections involves person-to-personspread.Our results suggest that a clonal outbreak of a T. indotineae strain is circulating in multiple states in India. Current plans are to expand the geographic scope of the study by including over 10 countries from Europe, Middle East, and the Americas. This work will allow the publichealth community to better understandthe emergence and transmissionof antifungal-resistant dermatophytosis worldwide.

Inhibitory effect of BDSF on hyphal growth of clinical Candida albicans

Synergistic Effect of Berberine Hydrochloride and Fluconazole Against Candida albicans Resistant Isolates

Effect and mechanism of berberine enhancement fluconazole to resistant Candida albicans

Mechanism and bioinformatics analysis of the effect of berberine-enhanced fluconazole against drug-resistant Candida albicans

In Vitro Synergism of Fluconazole and Baicalein Against Clinical Isolates of Candida Albicans Resistant to Fluconazole.

Influence of Prophylactic Application of Fluconazole on Antifungal Susceptibility to Strains of Candida Isolated from the Patients with High Risk of Deep Fungal Infections

Potent in Vitro Synergism of Fluconazole and Berberine Chloride Against Clinical Isolates of Candida Albicans Resistant to Fluconazole

Inhibition of berberine hydrochloride on Candida albicans biofilm formation

Synergistic Effect of the Combination of Deferoxamine and Fluconazole in Vitro and in Vivo Against Fluconazole-Resistant Candida Spp.

Discovery of BRD4-HDAC Dual Inhibitors with Improved Fungal Selectivity and Potent Synergistic Antifungal Activity Against Fluconazole-Resistant Candida Albicans.

cDNA microarray analysis of differential gene expression and regulation in clinically drug-resistant isolates of Candida albicans from bone marrow transplanted patients

Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans

Synergic Effect of Deferoxamine Combined with Fluconazole Against Fluconazole-Resistant Candida Spp. Through Inhibited Cek1 MAPK Signaling Pathway

The Effect of Ginkgolide B Combined with Fluconazole Against Drug-Resistant Candida Albicans Based on Common Resistance Mechanisms

The inhibition of trans-cinnamaldehyde on the virulence of Candida albicans via enhancing farnesol secretion with low potential for the development of resistance.

Clinical distribution and drug susceptibility and biological membrane type of Candida albicans infection

Inhibitory effects and mode of antifungal action of isobavachalcone on Candida albicans growth and virulence factors

Synergistic Effect of Doxycycline and Fluconazole Against Candida Albicans Biofilms and the Impact of Calcium Channel Blockers.

The expression of genes related to azole resistance and biofilm in Candida albicans

The Effect of Fluconazole in Combination with Rifampin in Vitro on Candida Albicans Biofilms

Antifungal activity of Cinnamaldehyde derivatives against fluconazole-resistant Candida albicans